Methodologies to assess moderate therapeutic effects

Authors

  • Álvaro Nagib Atallah

Downloads

Download data is not yet available.

Author Biography

Álvaro Nagib Atallah

MD, PhD, MSc, Associate professor of Internal Medicine of Escola Paulista de Medicina, President of the Latinclen Latin American Clinical Epidemiology Network.

References

Antiplatelet Trialist's Collaboration (ATC). Collaborative overview of randomized trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, BMJ 308: 71-72, 81-106, 1994. II: Maintenance of vascular graft or arterial patency by antiplatelet therapy - BMJ 308:159-168. III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylactics among surgical and medical patients - BMJ 308: 235-246, 1994.

ISIS-2 - Second International Study of Infarct Survival Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither, among 17,187 cases of suspected acute myocardial infarctions: ISIS-2 - Lancet ii:349-360, 1988.

Downloads

Published

1995-09-09

How to Cite

1.
Atallah Álvaro N. Methodologies to assess moderate therapeutic effects. Sao Paulo Med J [Internet]. 1995 Sep. 9 [cited 2026 Sep. 22];113(5):967. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/1692

Issue

Vol. 113 No. 5 (1995)

Section

Editorial

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.